Viewing data from:

VERSAPEN-K

ANDA

HETACILLIN POTASSIUM | A061396 | BRISTOL LABORATORIES INC DIV BRISTOL MYERS CO

2 strengths0 unique patents0 unique exclusivities

API Supply Chain1 active DMF3 inactive

1 active API supplier hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

FRESENIUS KABI IPSUM SRLHETACILLIN POTASSIUM STERILE

DMF 261892012

BRISTOL MYERS SQUIBB COInactiveHETACILLIN POTASSIUM

DMF 134281998

BRISTOL MYERS SQUIBB COInactiveHETACILLIN POTASSIUM

DMF 134301998

BRISTOL MYERS SQUIBB COInactiveHETACILLIN POTASSIUM

DMF 142131990

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — EQ 225MG AMPICIL

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Approved Prior to Jan 1, 1982

No patent or exclusivity listings for this strength.

#002 — EQ 450MG AMPICIL

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Approved Prior to Jan 1, 1982